Actual 10-year survival after resection of colorectal liver metastases defines cure.
By J. Tomlinson, W. Jarnagin, R. DeMatteo, Y. Fong, P. Kornprat, Mithat Gonen, N. Kemeny, M. Brennan, L. Blumgart, M. D'Angelica. Journal of Clinical Oncology, 2007
1,136 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/873ca50a3ff657f5724a7acf004dd1ce98db0098
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Cutsem
- A. Cervantes
- D. Arnold
- A. Sobrero
- R. Labianca
- René Adam
- S. Tejpar
- Fortunato Ciardiello
Citations in the corpus
- Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. (2009, background): “Retrospective studies in patients who undergo complete surgical resection suggest overall survival rates that exceed 50% at 5 years and range from 17% to 25% at 10 years.(6,7) Although these retrospective studies have been criticized for suffering from selection bias,(9) they demonstrate that long-t”
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. (2016, background): “The primary goal for patients who present with technically resectable liver metastases is clearly cure, with the primary goal R0 resection, although it should be noted that a 10-year follow up is required for confirmation of this [162].”
- Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors (2012, background): “130 Still, for the approximately 20% of patients with liver-limited metastases whose disease is determined to be resectable, 132 hepatectomy with curative intent is now the standard of care.”